Brexpiprazole for the treatment of acute schizophrenia in the Japanese populatio
- Conditions
- schizophrenia
- Registration Number
- JPRN-UMIN000032339
- Lead Sponsor
- Fujita Health University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Not provided
1. the patient with coma 2. the patient receiving anesthetic agent or barbiturate 3. the patient receiving epinephrine 4. the patient receiving psychostimulant 5. the patient having allergy brexpiprazole 6, the patient with DM 7. the patient with pregnancy 8. the patient with breast-feeding 9. the patient receiving clozapine 10. the patient suitable for clozapine 11. the patient who the clinician do not suggest to entry the study 12. the patient with mental retardation 13. the patient with dementia 14. the patient with personality disorder 15. the patient with organic brain disease and/or severe physical disease 16. the patient receiving paroxetine 17. the patient receiving carbamazepine 18. the patient receiving electroconvulsive therapy within 6 months before the study 19. the patient receiving long-acting injectable antipsychotics within 6 months before the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method All causes discontinuation
- Secondary Outcome Measures
Name Time Method Discontinuation due to adverse events, discontinuation due to inefficacy, the improvement of psychopathology, individual adverse events